Oncolytics Biotech Inc (ONCY)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $44.57M
Last updated: Nov 17, 2026 at 4:43 PM ET
Oncolytics Biotech Inc (ONCY) Stock Chart
Oncolytics Biotech (ONCY) has a latest price of $0.38 on Nov 17, 2026, 70.6% below its 52-week high of $1.30. Its price fell 63.2% over the past 12 months. The month-end price fell 93.0% since May 2018, a compound annual decline of 27.1%.
Price Chart
From May 2018 to Oct 2026, its highest month-end close was $6.10 in May 2018 and its lowest $0.34 in May 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart ONCY with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ONCY.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 54.0%, and over 6 months it fell 50.6%. The month-end price fell 74.4% over the 3 years through Oct 2026, a compound annual decline of 36.5%.
| Period | Change |
|---|---|
| 1 month | -22.9% |
| 3 months | -54.0% |
| 6 months | -50.6% |
| 12 months | -63.2% |
| 12 months, with dividends | -63.2% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -74.4% | -36.5% |
| 5 years | -79.1% | -26.9% |
| Since May 2018 | -93.0% | -27.1% |
Price by Year
Its best calendar year was 2019, when the price rose 163.0%, and its weakest was 2020, when it fell 50.0%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.43 | -51.3% |
| 2025 | $0.87 | -4.4% |
| 2024 | $0.91 | -32.3% |
| 2023 | $1.35 | -17.2% |
| 2022 | $1.63 | +17.3% |
| 2021 | $1.39 | -41.6% |
| 2020 | $2.38 | -50.0% |
| 2019 | $4.76 | +163.0% |
Trading Range
The price is 31.6% below its 50-day average of $0.56 and 53.5% below its 200-day average of $0.82.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.38 | |
| 52-week high | $1.30 | -70.6% |
| 52-week low | $0.34 | +13.8% |
| 50-day average | $0.56 | -31.6% |
| 200-day average | $0.82 | -53.5% |
Price Risk
Over 3 years, its largest fall from a peak was 80.0%.
| Measure | Value |
|---|---|
| 1-year beta | 1.23 |
| Largest fall, 1 year | -73.2% |
| Largest fall, 3 years | -80.0% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About ONCY
What is ONCY's 1-year price change?
Oncolytics Biotech's price fell 63.2% over the past 12 months. With dividends included, the 12-month total return was -63.2%.
What is ONCY's 5-year price change?
Oncolytics Biotech's month-end price fell 79.1% over the 5 years through Oct 2026, a compound annual decline of 26.9%. These figures leave out dividends.
What is ONCY's 52-week high and low?
Oncolytics Biotech's 52-week high is $1.30 and its 52-week low is $0.34. Its latest price of $0.38 on Nov 17, 2026 is 70.6% below the high.
What is ONCY's beta?
Oncolytics Biotech's 1-year beta against the S&P 500 is 1.23, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 73.2%.
Is the ONCY chart free?
Yes. Advanced Charting for ONCY is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
ONCY pages: Overview, Charting, Competitors